search
Back to results

Evaluation of Repetitive Transcranial Magnetic Stimulation as an Adjunct to Modified Constraint Induced Movement Therapy in Improving Upper Limb Function in Children With Hemiparetic Cerebral Palsy Aged 5 - 18 Years

Primary Purpose

Hemiparetic Cerebral Palsy

Status
Unknown status
Phase
Not Applicable
Locations
India
Study Type
Interventional
Intervention
mCIMT with real rTMS
mCIMT with sham rTMS
Sponsored by
All India Institute of Medical Sciences, New Delhi
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Hemiparetic Cerebral Palsy focused on measuring Transcranial Magnetic Stimulation (TMS), modified Constraint Induced Movement Therapy (mCIMT)

Eligibility Criteria

5 Years - 18 Years (Child, Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • • Age 5 - 18 years

    • Hemiparetic Cerebral Palsy (perinatal brain injury)
    • Intelligence Quotient >70 (Binet Kamat Test/Malin's Intelligence Scale for Children)
    • Modified Ashworth scoring 1-3 for affected limb
    • Can sit independently or with support (GMFCS stage : 1-4 and Manual Ability Classification System stage: 1-3)
    • Preserved vision and hearing (with or without correction)

Exclusion Criteria:

  • • Uncontrolled epilepsy as defined by seizure frequency >1/month for preceding 3 months

    • Severe concurrent illness or disease not associated with CP or unstable medical conditions like pneumonia
    • Genetic or syndromic associations
    • Children diagnosed with Autistic Spectrum Disorders
    • Modified Ashworth Scale Score more than 3 at shoulder/elbow/wrist
    • Contractures of affected limb
    • Severe movement disorder like dystonia, choreo-athetosis or ballismus interfering with purposeful limb movement
    • Any congenital brain malformation detected on conventional MRI brain
    • Recent surgery/cast/splint in affected limb
    • Botulinum toxin/phenol block in affected limb in past 6 months or planned to receive in study period
    • Those receiving tone modifying agents within two weeks before enrolment (Tizanidine, baclofen, benzodiazepines, dantrolene)
    • mCIMT received in last 6 months
    • Any contraindications for TMS - implanted electronic device and non-removable metallic objects near coil e.g. Pacemaker, cochlear implant

Sites / Locations

  • India

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Sham Comparator

Arm Label

mCIMT with real rTMS

mCIMT with sham rTMS

Arm Description

Modified Constraint Induced Movement Therapy (mCIMT) with real Repetitive Transcranial Magnetic Stimulation (rTMS). 10 sessions of mCIMT will be administered using physical rehabilitation protocol along with real rTMS over contralateral primary motor cortex.

Modified Constraint Induced Movement Therapy with sham Repetitive Transcranial Magnetic Stimulation (using sham coil). 10 sessions of mCIMT will be administered using physical rehabilitation protocol along with sham rTMS over contralateral primary motor cortex using sham coil which simulated sound and touch of real coil but has no electro-magnetic waves.

Outcomes

Primary Outcome Measures

Efficacy of 4 weeks of mCIMT with sham/real rTMS
◦ To evaluate the efficacy of repetitive Transcranial Magnetic Stimulation (rTMS) as an adjunct to modified Constraint Induced Movement Therapy (mCIMT) for 4 weeks in improving the Upper Limb Function as per increase in total QUEST score by 5 in 5-18 years old children with Hemiparetic Cerebral Palsy

Secondary Outcome Measures

To evaluate improvement in dissociated movements, grasp, weight bearing and protective extension in each group at the end of 4 weeks
To evaluate improvement in dissociated movements, grasp, weight bearing and protective extension in each group at the end of 4 weeks
To evaluate improvement in speed of upper limb movements in each group at the end of 4 weeks
To evaluate improvement in speed of upper limb movements in each group at the end of 4 weeks
To evaluate improvement in muscle strength in each group at the end of 4 weeks
To evaluate improvement in muscle strength in each group at the end of 4 weeks
To assess improvement in quality of life after the intervention in each group
To assess improvement in quality of life after the intervention in each group
To assess compliance to therapy in each group by Daily Compliance Log
To assess compliance to therapy in each group by Daily Compliance Log
To study for adverse events of TMS
To study for adverse events of TMS
To evaluate cortical excitability with TMS at baseline and the end of 4 weeks
To evaluate cortical excitability with TMS at baseline and the end of 4 weeks
• To evaluate sustenance of improvement by change in QUEST score at the end of 12 weeks, 8 weeks after stopping supervised treatment in both the groups
• To evaluate sustenance of improvement by change in QUEST score at the end of 12 weeks, 8 weeks after stopping supervised treatment in both the groups

Full Information

First Posted
December 19, 2018
Last Updated
January 2, 2019
Sponsor
All India Institute of Medical Sciences, New Delhi
search

1. Study Identification

Unique Protocol Identification Number
NCT03792789
Brief Title
Evaluation of Repetitive Transcranial Magnetic Stimulation as an Adjunct to Modified Constraint Induced Movement Therapy in Improving Upper Limb Function in Children With Hemiparetic Cerebral Palsy Aged 5 - 18 Years
Official Title
Evaluation of Repetitive Transcranial Magnetic Stimulation as an Adjunct to Modified Constraint Induced Movement Therapy in Improving Upper Limb Function in Children With Hemiparetic Cerebral Palsy Aged 5 - 18 Years - A Randomized Controlled Trial
Study Type
Interventional

2. Study Status

Record Verification Date
January 2019
Overall Recruitment Status
Unknown status
Study Start Date
January 15, 2019 (Anticipated)
Primary Completion Date
August 1, 2020 (Anticipated)
Study Completion Date
August 30, 2020 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
All India Institute of Medical Sciences, New Delhi

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The investigators aim to evaluate efficacy of TMS as an adjunct to CIMT, assess its safety and tolerability and study cortical excitability with help of TMS which are both rehabilitative therapies for hemiplegic cerebral palsy.
Detailed Description
Cerebral palsy is the most common motor disability of childhood and Hemiparetic cerebral palsy accounts for about one third of cases. Improving spasticity and upper limb function in these children can lead to better functional outcome and quality of life. TMS is an upcoming rehabilitative modality which has shown promising results in western studies. It has benefits of being non-invasive and has shown to have additive effect when used with CIMT which is standard of care in hemiparetic CP. However, randomized controlled clinical trials comparing it with CIMT alone in hemiparetic CP are very few, none from India so far. The dose, type and duration of TMS and its feasibility in resource limited set up needs to be investigated in children .Therefore, the investigators aim to evaluate efficacy of TMS as an adjunct to CIMT, assess its safety and tolerability and study cortical excitability with help of TMS.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hemiparetic Cerebral Palsy
Keywords
Transcranial Magnetic Stimulation (TMS), modified Constraint Induced Movement Therapy (mCIMT)

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantOutcomes Assessor
Allocation
Randomized
Enrollment
40 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
mCIMT with real rTMS
Arm Type
Experimental
Arm Description
Modified Constraint Induced Movement Therapy (mCIMT) with real Repetitive Transcranial Magnetic Stimulation (rTMS). 10 sessions of mCIMT will be administered using physical rehabilitation protocol along with real rTMS over contralateral primary motor cortex.
Arm Title
mCIMT with sham rTMS
Arm Type
Sham Comparator
Arm Description
Modified Constraint Induced Movement Therapy with sham Repetitive Transcranial Magnetic Stimulation (using sham coil). 10 sessions of mCIMT will be administered using physical rehabilitation protocol along with sham rTMS over contralateral primary motor cortex using sham coil which simulated sound and touch of real coil but has no electro-magnetic waves.
Intervention Type
Device
Intervention Name(s)
mCIMT with real rTMS
Intervention Description
Modified constraint induced movement therapy will be provided to all children according to predefined protocol. rTMS will be provided using figure of eight shaped coil and TMS stimulator ((Magventure Denmark, X100 with mapoption) over contra-lesional primary motor cortex over 10 sessions of 20 minutes each spread over 4 weeks. Each session will comprise priming ( 10 minutes of 6Hz rTMS at 90% of resting motor threshold, delivered in two trains per minute with 5 seconds per train and 25-seconds intervals between trains (a total of 600 priming pulses)). Priming will be followed immediately by additional 10 minutes of 1Hz rTMS at 90% of resting motor threshold without interruption (a total of 600 low-frequency pulses).
Intervention Type
Device
Intervention Name(s)
mCIMT with sham rTMS
Intervention Description
Modified constraint induced movement therapy will be provided to all children according to predefined protocol. Sham rTMS will be given using a sham coil.
Primary Outcome Measure Information:
Title
Efficacy of 4 weeks of mCIMT with sham/real rTMS
Description
◦ To evaluate the efficacy of repetitive Transcranial Magnetic Stimulation (rTMS) as an adjunct to modified Constraint Induced Movement Therapy (mCIMT) for 4 weeks in improving the Upper Limb Function as per increase in total QUEST score by 5 in 5-18 years old children with Hemiparetic Cerebral Palsy
Time Frame
Within 1 week of end of 4 weeks of mCIMT with sham/real rTMS
Secondary Outcome Measure Information:
Title
To evaluate improvement in dissociated movements, grasp, weight bearing and protective extension in each group at the end of 4 weeks
Description
To evaluate improvement in dissociated movements, grasp, weight bearing and protective extension in each group at the end of 4 weeks
Time Frame
within 1 week of end of 4 weeks of mCIMT with sham/real rTMS
Title
To evaluate improvement in speed of upper limb movements in each group at the end of 4 weeks
Description
To evaluate improvement in speed of upper limb movements in each group at the end of 4 weeks
Time Frame
within 1 week of end of 4 weeks of mCIMT with sham/real rTMS
Title
To evaluate improvement in muscle strength in each group at the end of 4 weeks
Description
To evaluate improvement in muscle strength in each group at the end of 4 weeks
Time Frame
within 1 week of end of 4 weeks of mCIMT with sham/real rTMS
Title
To assess improvement in quality of life after the intervention in each group
Description
To assess improvement in quality of life after the intervention in each group
Time Frame
within 1 week of end of 4 weeks of mCIMT with sham/real rTMS
Title
To assess compliance to therapy in each group by Daily Compliance Log
Description
To assess compliance to therapy in each group by Daily Compliance Log
Time Frame
within 1 week of end of 4 weeks of mCIMT with sham/real rTMS
Title
To study for adverse events of TMS
Description
To study for adverse events of TMS
Time Frame
within 1 week of end of 4 weeks of mCIMT with sham/real rTMS
Title
To evaluate cortical excitability with TMS at baseline and the end of 4 weeks
Description
To evaluate cortical excitability with TMS at baseline and the end of 4 weeks
Time Frame
within 1 week of end of 4 weeks of mCIMT with sham/real rTMS
Title
• To evaluate sustenance of improvement by change in QUEST score at the end of 12 weeks, 8 weeks after stopping supervised treatment in both the groups
Description
• To evaluate sustenance of improvement by change in QUEST score at the end of 12 weeks, 8 weeks after stopping supervised treatment in both the groups
Time Frame
within 1 week of end of 4 weeks of mCIMT with sham/real rTMS

10. Eligibility

Sex
All
Minimum Age & Unit of Time
5 Years
Maximum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: • Age 5 - 18 years Hemiparetic Cerebral Palsy (perinatal brain injury) Intelligence Quotient >70 (Binet Kamat Test/Malin's Intelligence Scale for Children) Modified Ashworth scoring 1-3 for affected limb Can sit independently or with support (GMFCS stage : 1-4 and Manual Ability Classification System stage: 1-3) Preserved vision and hearing (with or without correction) Exclusion Criteria: • Uncontrolled epilepsy as defined by seizure frequency >1/month for preceding 3 months Severe concurrent illness or disease not associated with CP or unstable medical conditions like pneumonia Genetic or syndromic associations Children diagnosed with Autistic Spectrum Disorders Modified Ashworth Scale Score more than 3 at shoulder/elbow/wrist Contractures of affected limb Severe movement disorder like dystonia, choreo-athetosis or ballismus interfering with purposeful limb movement Any congenital brain malformation detected on conventional MRI brain Recent surgery/cast/splint in affected limb Botulinum toxin/phenol block in affected limb in past 6 months or planned to receive in study period Those receiving tone modifying agents within two weeks before enrolment (Tizanidine, baclofen, benzodiazepines, dantrolene) mCIMT received in last 6 months Any contraindications for TMS - implanted electronic device and non-removable metallic objects near coil e.g. Pacemaker, cochlear implant
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Sheffali Gulati, MD
Phone
09810386847
Email
sheffaligulati@gmail.com
First Name & Middle Initial & Last Name or Official Title & Degree
Juhi Gupta, MD
Phone
9999630637
Email
juhiguptadr@gmail.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Sheffali Gulati, MD
Organizational Affiliation
All India Institute of Medical Sciences, New Delhi
Official's Role
Principal Investigator
Facility Information:
Facility Name
India
City
New Delhi
ZIP/Postal Code
110029
Country
India
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Sheffali Gulati, MD
Phone
011-26594679
Email
sheffaligulati@gmail.com

12. IPD Sharing Statement

Plan to Share IPD
Undecided

Learn more about this trial

Evaluation of Repetitive Transcranial Magnetic Stimulation as an Adjunct to Modified Constraint Induced Movement Therapy in Improving Upper Limb Function in Children With Hemiparetic Cerebral Palsy Aged 5 - 18 Years

We'll reach out to this number within 24 hrs